GEN Exclusives

More »

GEN News Highlights

More »
Apr 30, 2008

Dr. Reddy’s Expands U.S. Presence with Purchase of BASF’s Contract Manufacturing Franchise

  • Dr. Reddy’s Laboratories plans to acquire BASF’s pharmaceutical contract manufacturing business and related facility in Shreveport, LA. The transaction is expected to close by the first quarter of fiscal year 2009.

    This segment of BASF involves the manufacturing of generic prescription and over-the-counter products for branded and generic companies in the U.S. It reportedly recorded revenues of $43 million for  2007.

    Dr. Reddy’s will gain customer contracts, related ANDAs and NDAs, and trademarks. The Louisiana facility, which will also come under Dr. Reddy’s control, is designed to manufacture solid, semisolid, and liquid-dosage forms.

    “The acquisition of BASF’s finished-dosage manufacturing facility in the U.S. will enable us to strengthen our supply chain for North America and provide a strong platform for pursuing additional growth opportunities,” notes Satish Reddy, managing director and COO.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?